Gapping down
In reaction to disappointing earnings/guidance:
- UNXL -27.3%, (also discloses entry into equity purchase agreement with L2 Capital relating to an offering of an aggregate of up to 14,146,649 shares ), JCP -22.5%, LXFT -17.8%, SNAP -11.3%, NVDA -8.4%, BBOX -7.4%, UPLD -6.3%, KINS -5.4%, SPHS -5.2%, BIOC -4.8%, CXRX -4.6%, CBAY -3.9%, TU -1.6%, MGA -1%
Select China related names showing weakness after Shanghai closed down 1.6% overnight:
- WB -2.9%, NTES -2.6%, MOMO -2.6%, SINA -2%, CTRP -2%, BIDU -1.6%, JD -1.5%
Select NVDA peers/related names trading lower:
- AMD -2.3%, MU -1.6%, SOXX -1.2%, XLNX -1%
Other news:
- ETRM -35.3% ( commences public offering to consist of units comprised of one share of series B convertible preferred stock and one warrant to purchase shares of common stock)
- IONS -6.3% (announces 'a reprioritization of its pipeline and strategic review of its Rare Diseases business', after GSK (GSK) declined its options on inotersen and IONIS-FB-LRx)
- NCLH -4% (launches secondary public offering of 15 million of its ordinary shares by certain funds affiliated with Apollo Global, Star NCLC Holdings Ltd. and certain funds affiliated with TPG Global)
- TXMD -3.5% (announces regulatory update regarding the NDA for TX-004HR)
- CBI -2.7% (continued weakness)
- SQ -1.6% (continued weakness - closed down nearly 4% today)
- LYV -1.5% (following late move lower on reports that Amazon may sell event tickets)
- KSS -1.1% (in sympathy with JCP)
Analyst comments:
- LTC -1.7% (downgraded to Underperform at BMO Capital Markets)
- KR -1% (initiated with a Underweight )
- NNA -0.7% (downgraded to Neutral at Citigroup)
- FRTA -0.6% (downgraded to Equal Weight from Overweight at Barclays)
- SHPG -0.5% (downgraded to Equal Weight from Overweight at Barclays )
- GS -0.5% (downgraded to Hold from Buy at HSBC Securities)
